Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: AcuCort AB

Market Cap 153M 16.32M 14.09M 12.99M 12.15M 22.78M 1.55B 23.13M 59.78M 755M 61.23M 59.93M 2.61B P/E Ratio 2024
-3.61x
P/E Ratio 2025 -5x
Enterprise Value 126M 13.44M 11.61M 10.7M 10.01M 18.77M 1.28B 19.06M 49.25M 622M 50.44M 49.37M 2.15B EV / Sales 2024
11.3x
EV / Sales 2025 17x
Free-Float
36.58%
Yield 2024 *
-
Yield 2025 -
1 day+1.55%
1 week-3.82%
Current month-5.22%
1 month-7.89%
3 months+13.74%
6 months+18.48%
Current year+9.00%
1 week 0.62
Extreme 0.624
0.7
1 month 0.62
Extreme 0.624
0.74
Current year 0.5
Extreme 0.499
0.95
1 year 0.5
Extreme 0.499
0.95
3 years 0.33
Extreme 0.327
1.45
5 years 0.33
Extreme 0.327
5.42
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 2020-08-08
Corporate Officer/Principal 53 2025-10-13
Director TitleAgeSince
Director/Board Member 68 2017-02-07
Chairman 63 2017-12-31
Director/Board Member 79 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.55%-3.82%-14.40%-53.29% 15.82M
-0.37%+0.64%-7.11%-25.82% 15.53B
+2.93%-1.68%-23.70%-26.88% 7.03B
-1.02%+2.14%-16.55%-11.11% 5.78B
+4.47%+10.41%-14.44%-25.00% 3.73B
-0.24%-0.22%-37.51%-9.80% 3.33B
-1.21%-2.33%-25.36%-45.30% 3.26B
+4.44%+6.84%+3.56%-35.99% 2.76B
+0.02%+5.61%+113.74% - 2.73B
0.00%-1.48%-25.09%-6.16% 2.56B
Average +1.06%+1.63%-4.69%-26.59% 4.67B
Weighted average by Cap. +0.71%+1.17%-8.10%-23.72%

Financials

2024 2025
Net sales 7.72M 821K 709K 654K 612K 1.15M 78.05M 1.16M 3.01M 37.99M 3.08M 3.02M 132M 6.68M 711K 614K 566K 530K 993K 67.59M 1.01M 2.61M 32.9M 2.67M 2.61M 114M
Net income -17.4M -1.85M -1.6M -1.47M -1.38M -2.58M -176M -2.62M -6.78M -85.65M -6.95M -6.8M -297M -26.19M -2.79M -2.41M -2.22M -2.08M -3.89M -265M -3.95M -10.21M -129M -10.46M -10.24M -446M
Net Debt -2.77M -295K -255K -235K -220K -412K -28.04M -418K -1.08M -13.65M -1.11M -1.08M -47.25M -27.01M -2.87M -2.48M -2.29M -2.14M -4.01M -273M -4.08M -10.53M -133M -10.79M -10.56M -460M
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
5
Date Price Change Volume
26-06-11 0.6540 kr +1.55% 321,333
26-06-11 0.6440 kr -1.53% 158,702
26-06-10 0.6540 kr -0.61% 180,673
26-06-09 0.6580 kr 0.00% 182,090
26-06-08 0.6580 kr -3.24% 183,512
  1. Stock Market
  2. Stocks
  3. ACUC Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!